11 results
·
21ms
·
Sources: EU EUDAMED, US FDA
Filters
Regulation: Us FDA
×
PANTHER OIS/R & V MODEL VERSION 2.0
FDA 510(k)
FDA Class 2
·Radiology
APEX PS Knee
FDA UDI
Omni Life Science, Inc.·00841690113812·PS-C Insert, Size 6 x 16mm
Spine Innovation Interbody System
FDA UDI
SPINE INNOVATION, LLC·00817722020397·Expandable Implant 5° x 12mm W x 16mm H x 26mm L
NAVIAID BALLOON GUIDED COLONOSCOPY (BGC) DEVICE
FDA 510(k)
FDA Class 2
·Gastroenterology, Urology
NITIBOND STAPES PROSTHESIS, NITIPLAST STAPES PROSTHESIS
FDA 510(k)
FDA Class 2
·Ear, Nose, Throat
FMP HIP
FDA Adverse Event
Other
·ENCORE MEDICAL, L.P.·Product code KWA·May 15, 2013
PRECISION®
FDA Adverse Event
Injury
·BOSTON SCIENTIFIC NEUROMODULATION·Product code LGW·September 26, 2014
INSYNC MAXIMO
FDA Adverse Event
Injury
·MEDTRONIC MED REL, INC.·Product code NIK·June 14, 2011
Calcium Arsenazo, CALA-0250, For the Quantitative Determination of Total Calcium in Human Serum. The kit label shows CALCIUM ARSENAZO, CALA-0250, R: 12x20 mL. The vial's label shows CALCIUM ARSENAZO, CALA-5220, 20 mL, . CALCIUM ARSENAZO is intended use for the quantitative in vitro diagnostic determination of total calcium in human serum and plasma on ELITech Clinical Systems Selectra Pro Series Analyzers. Calcium measurements are used in the diagnosis and treatment of parathyroid disease, a variety of bone diseases, chronic renal disease and tetany (intermittent muscular contractions or spasms). It is not intended for use in Point of Care setting.
FDA Enforcement
Class II
·Terminated·SEPPIM SAS·November 13, 2013
Eversense CGM SENSOR (FG-4200-00-301)-Continuous Glucose Monitor
FDA Enforcement
Class II
·Terminated·Senseonics, Inc.·November 6, 2019
Exactech Equinoxe CAGE GLENOID,POSTERIOR AUGMENT, CEMENTED, Left, Mates with: a) 38, 41, 44, 47 head, Small, Item Number 314-13-22, b) 41, 44, 47, 50, head, Medium, Item Number 314-13-23, c) 44, 47, 50, 53 head, Large, Item Number 314-13-24, d) 44, 47, 50, 53 head, Extra Large, Item Number 314-13-25; Shoulder Arthroplasty
FDA Enforcement
Class II
·Ongoing·Exactech, Inc.·April 10, 2024